Decathlon Capital Partners will support the expansion of Amprion's diagnostic testing capacity for neurodegenerative diseases such as Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The post Decathlon invests in diagnostics firm Amprion Inc appeared first on PE Hub.
Continue Reading
Sign up for FREE to read the full article and access 149K+ alternative investment headlines.